Skip to content

Metabolic Availability of Lysine From White Maize

Application of the Indicator Amino Acid Oxidation Technique for the Determination of Metabolic Availability of Lysine From White Maize Protein, in Young Adult Men

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02018575
Enrollment
7
Registered
2013-12-23
Start date
2013-12-31
Completion date
2016-05-31
Last updated
2016-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Keywords

lysine, bioavailability, amino acids, corn

Brief summary

Our objective is to determine the metabolic availability of Lysine in white maize using the indicator amino acid oxidation (IAAO) technique in adult men.

Detailed description

Our objective is to determine the metabolic availability of Lysine in white maize. 7 young, healthy, male adults will receive graded levels (29, 37,46 and 54%) of lysine requirement of 35 mg/kg/d as a crystalline AA mixture and a porridge of white cornmeal protein respectively.

Interventions

DIETARY_SUPPLEMENTCrystalline Lysine Amino Acid Mix

Crystalline Lysine from Amino Acid Mixture in amount of 29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects.

DIETARY_SUPPLEMENTWhite corn meal porridge

A cornmeal porridge including 29, 37, 46 and 54% of the mean Lysine requirement of 35 mg/kg/d will be given to subjects.

Sponsors

The Hospital for Sick Children
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
20 Years to 49 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Adult males (20-49 years old)

Exclusion criteria

* A history of recent weight loss or illness * Use of any medication at the time of entry into the study

Design outcomes

Primary

MeasureTime frameDescription
Metabolic Availability of LysineBaseline3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.

Secondary

MeasureTime frameDescription
Metabolic Availability of Lysine15 mins after intake of the fourth hourly meal (before tracer infusion)3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.

Other

MeasureTime frameDescription
Metabolic availability of Lysine30 mins after intake of the fourth hourly meal (before tracer infusion)3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.
Metabolic Availability of Lysine45 mins after intake of the fourth hourly meal (before tracer infusion)3 breath samples will be taken to provide a baseline F13CO2 measurement (Level of Phenylalanine oxidation). Breath samples will be collected and analyzed for 13CO2 enrichment.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026